Compass Therapeutics (CMPX) Return on Assets (2023 - 2025)
Historic Return on Assets for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to 0.4%.
- Compass Therapeutics' Return on Assets fell 800.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.38% for FY2024, which is N/A changed from last year.
- As of Q3 2025, Compass Therapeutics' Return on Assets stood at 0.4%, which was down 800.0% from 0.54% recorded in Q2 2025.
- Compass Therapeutics' 5-year Return on Assets high stood at 0.26% for Q4 2023, and its period low was 0.54% during Q2 2025.
- For the 3-year period, Compass Therapeutics' Return on Assets averaged around 0.36%, with its median value being 0.34% (2024).
- Over the last 5 years, Compass Therapeutics' Return on Assets had its largest YoY gain of -800bps in 2025, and its largest YoY loss of -2400bps in 2025.
- Quarter analysis of 3 years shows Compass Therapeutics' Return on Assets stood at 0.26% in 2023, then crashed by -40bps to 0.36% in 2024, then fell by -11bps to 0.4% in 2025.
- Its Return on Assets stands at 0.4% for Q3 2025, versus 0.54% for Q2 2025 and 0.43% for Q1 2025.